Previous close | 55.10 |
Open | 55.15 |
Bid | 55.51 x 200 |
Ask | 55.61 x 200 |
Day's range | 54.82 - 55.74 |
52-week range | 42.75 - 59.86 |
Volume | |
Avg. volume | 667,571 |
Market cap | 2.996B |
Beta (5Y monthly) | 0.94 |
PE ratio (TTM) | 173.53 |
EPS (TTM) | 0.32 |
Earnings date | 01 May 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 67.56 |
LONDON, April 25, 2024--LivaNova's wholly-owned U.S. subsidiary, LivaNova USA, Inc., is providing notice to U.S. patients regarding a cybersecurity incident in late 2023.
Tandem Diabetes Care (TNDM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
LivaNova (LIVN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.